In these experiments, we assessed the role of hepatocyte lysosomes in biliary excretion of iron. We loaded rats with iron by feeding 2% carbonyl iron and collected bile for 24 h via bile fistulae from iron-loaded and control rats. In additional rats, bile was collected before and after the administration of colchicine. Rats were then killed and their livers were homogenized and fractionated for biochemical analyses or processed for electron microscopy and x-ray microanalysis. Inclusion of 2% carbonyl iron in the diet caused a 45-fold increase (P < 0.001) in hepatic iron concentration compared with controls (1,826±159 vs. 38±6.7 ,gg/g liver, mean±SE (6) and is a microtubule-dependent process (7). Thus, our studies have been consistent with the possibility that this lysosome-tobile hepatic excretory pathway is involved in the metabolism and subsequent biliary excretion of a variety of circulating molecules (e.g., proteins [8] , lipoproteins [9] , and trace metals) destined for sequestration in hepatocyte lysosomes.
Introduction
In these experiments, we assessed the role of hepatocyte lysosomes in biliary excretion of iron. We loaded rats with iron by feeding 2% carbonyl iron and collected bile for 24 h via bile fistulae from iron-loaded and control rats. In additional rats, bile was collected before and after the administration of colchicine. Rats were then killed and their livers were homogenized and fractionated for biochemical analyses or processed for electron microscopy and x-ray microanalysis. Inclusion of 2% carbonyl iron in the diet caused a 45-fold increase (P < 0.001) in hepatic iron concentration compared with controls (1,826±159 vs. 38±6.7 ,gg/g liver, mean±SE). Electron microscopy with quantitative morphometry and x-ray microanalysis showed that the excess iron was sequestered in an increased number of lysosomes concentrated in the pericanalicular region of the hepatocyte. Iron loading was also associated with a twofold increase in biliary iron excretion (4.06±0.3 vs. 1.75±0.1 pg/g liver/24 h; P < 0.001). In contrast, the biliary outputs of three lysosomal enzymes were significantly lower (P < 0.0005) in iron-loaded rats compared with controls (mean±SE) expressed as mU/24 h/g liver: N-acetyl-B-glucosaminidase, 26 .7±4.6 vs. 66.2±13A; 0-glucuronidase, 10.1±13 vs. 53.2±17.9; 9-galactosidase, 8 .9±1.0 vs. 15 .4±23. In iron-loaded rats but not in controls, biliary iron excretion was coupled to the release into bile of each of the three lysosomal hydrolases as assessed by linear regression analysis (P < 0.001). In contrast, no relationships were found between biliary iron excretion and the biliary outputs of a plasma membrane marker enzyme (alkaline phosphodiesterase I) or total protein. After administration of colchicine, there was a parallel increase in biliary excretion of iron and lysosomal enzymes in iron-loaded rats, but not controls. We interpret these data to indicate that, in the rat, biliary iron excretion from hepatocyte lysosomes is an important excretory route for excess hepatic iron.
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Lysosomes are intracellular, membrane-bound organelles that contain over 40 hydrolytic enzymes with an acid pH optimum. The major functions of lysosomes include intracellular digestion, transcellular transport, extracellular release or secretion of their contents, and the sequestration and storage of endogenous or exogenous cell components (1) . Several years ago, we proposed that exocytosis of lysosomal contents into biliary canaliculi was an important excretory pathway in the liver (2), a hypothesis originally suggested by de Duve and Wattiaux (3) . Subsequent studies have produced results consistent with this hypothesis and have included: (a) the demonstration of coordinate release of several lysosomal hydrolases into bile under basal (2) and cholestatic (4) conditions; (b) the observation that an exogenous lysosomotropic agent is excreted into bile in parallel with endogenous lysosomal constituents under basal (5) or stimulated conditions; and (c) the finding that the biliary excretion of lysosomal enzymes can be altered by pharmacologic agents (6) and is a microtubule-dependent process (7) . Thus, our studies have been consistent with the possibility that this lysosome-tobile hepatic excretory pathway is involved in the metabolism and subsequent biliary excretion of a variety of circulating molecules (e.g., proteins [8] , lipoproteins [9] , and trace metals) destined for sequestration in hepatocyte lysosomes.
It is well known that iron may accumulate in the liver in genetic hemochromatosis (10), after multiple blood transfusions ( 1) or excessive oral intake of iron (12) . In all these disorders, the excess hepatic iron conspicuously accumulates in hepatocyte lysosomes, as shown by both biochemical (13) and morphologic (14) studies. The mechanism whereby iron is sequestered in hepatocyte lysosomes in conditions ofiron overload is not known. Nevertheless, the consistent pericanalicular location ofiron-laden lysosomes within hepatocytes and the demonstration that there are significant amounts of iron in bile (15) has led investigators to suggest that iron may be released into bile directly from hepatocyte lysosomes by exocytosis after fusion of lysosomes with the canalicular membrane. There is, however, no direct morphologic or biochemical evidence for the existence of this excretory pathway.
Therefore, we examined in detail the role of hepatocyte lysosomes in the biliary excretion of iron. To this end, we applied an animal model of iron overload to examine the subcellular distribution of iron in the livers of normal and iron-loaded rats, assessed the relationship between biliary iron excretion and the release into bile of lysosomal and plasma membrane enzymes, and examined the effect of a microtubule binding agent, colchicine, on biliary iron excretion. Our results show that, in the condition of hepatic iron overload, excess iron is sequestered in hepatocyte lysosomes, biliary iron excretion is increased, the accelerated release of excess iron into bile is closely coupled to biliary excretion of lysosomal but not plasma membrane en-zymes, and colchicine augments biliary excretion of both iron and lysosomal enzymes in a coordinate fashion.
Methods
General experimental procedure. Male Sprague Dawley rats were fed either standard laboratory chow (Ralston Purina Co., St. Louis, MO) or laboratory chow containing 2% carbonyl iron (Ralston Purina Co.) according to the method of Bacon et al. (16) for up to 6 mo. The rats were permitted free access to food and water until 7 a.m. on the morning of the experiment.
In one group of experiments, control rats (n = 10) and iron-fed rats (n = 9) were weighed and complete bile fistulae were created under pentobarbital anesthesia (40 mg/kg body weight) as previously described (2) . After surgery, rats were placed in restraining cages and bile was collected into preweighed, acid-washed polypropylene containers in 2-hourly aliquots for 24 h.
In another set of experiments, additional iron-loaded (n = 11) and control (n = I 1) animals had bile fistulae established and anesthesia maintained with repeated doses ofintraperitoneal sodium pentobarbital. Tracheostomies were performed to facilitate respiration, 5% dextrose was infused into the femoral vein at 1.5 ml/h, and animals were placed in a constant temperature-humidity apparatus where bile was collected for a total of 8 h. After 4 h ofbile collection as a baseline, we administered either colchicine (5 ,mol/kg body weight) or normal saline and collected bile for an additional 4 h.
Rats from each set of experiments were killed by exsanguination after bile collection for either 24 (5, 17) . In some experiments, the latent hydrolase activity in E-fractions of rat liver, expressed as a percent of total activity, was determined for N-acetyl-fl-glucosaminidase by subtracting free activity (activity in the absence of 0.1% Triton X-100 in the assay mix) from total activity (activity in the presence of 0.1% Triton X-100 in the assay mix), dividing this number by total activity, and multiplying by 100. This value normally is 80-85% of the total hepatic lysosomal enzyme activity and is an indirect measurement of the integrity of lysosomal membranes (3) .
In a third set of experiments, the subcellular distribution of iron was determined in control and iron-loaded rats by differential centrifugation ofrat liver using an ultracentrifuge (L2-65B; Beckman Instruments, Inc., Fullerton, CA) as previously described (5, 17) . In these studies, the Efraction prepared by low-speed centrifugation was further separated into four additional fractions enriched in mitochondria (heavy mitochondrial or M-fraction), lysosomes (light mitochondrial or L-fraction), endoplasmic reticulum (P-fraction), and cytosol (final supernatant or S-fraction).
Analyticalprocedures. Three Iron determinations were performed using atomic absorption spectrophotometry (model 5000; Elmer-Perkins, Norwalk, CT) (24) . Bile was acidified with 1 N nitric acid (1:1, vol/vol) to solubilize iron hydroxides before iron measurements.
Morphologic studies. Livers were obtained for morphology from a separate group of iron-loaded and control rats. In these studies, livers were fixed by perfusion in situ with Trump's fixative (25) , containing 4% formaldehyde and 1% glutaraldehyde in a 0.2 M sodium phosphate buffer, pH 7.2, for 10 min. Then 2-mm cubes of liver were cut and placed in the same fixative for 2 h at 4VC and then rinsed overnight in phosphate buffer. For light microscopy, liver was embedded in paraffin and stained with Perls stain for iron (26) . For electron microscopy, liver was postfixed in 1% osmium tetroxide, dehydrated in a graded series of ethanol, and embedded in Spurr's low-viscosity epoxy resin (27) . Thin sections were cut with a diamond knife on an ultramicrotome (LKB Instruments, Inc., Gaithersburg, MD), stained with 3% aqueous uranyl acetate and 0.3% aqueous lead citrate, and examined with a transmission electron microscope (400; Philips Electronic Instruments, Inc., Mahwah, NJ).
Quantitative morphometry was performed to assess the distribution of lysosomes in the pericanalicular areas as previously described (6) . A 2-Aim radius was arbitrarily defined as the pericanalicular area, and the number of lysosomes within that area counted at a print magnification of 22,500. 12 randomly selected liver plates were counted for each rat, and the specimens were coded so the electron microscopist was unaware of the treatment protocol. Lysosomes were defined morphologically as single, round, or ovoid, electron-dense bodies, limited by a unit membrane.
X-ray microanalysis. X-ray microanalysis in combination with electron microscopy using an x-ray energy spectroscopy system (7000; Kevex Corp., Foster City, CA) interfaced with an electron microscope (EM 400; Philips Electronic Instruments, Inc.) was performed on rat liver (28) to determine semiquantitatively the subcellular distribution of iron. Briefly, an electron beam (500 nm spot size) is focused on the subcellular area ofinterest. A characteristic x-ray spectrum is emitted for iron; the emission intensity depends on the amount of iron present in the probed area.
Lysosomal and nonlysosomal (cytosol) areas were probed, and the relative amounts of iron in these subcellular locations were quantified.
Statistical methods. The two groups of rats in the 24-h studies were compared with regard to body weight, liver weight, and total 24-h bile flow using a two-sample independent t test. Hepatic concentrations of lysosomal enzymes and iron, and the 24-h total outputs ofenzymes and iron were compared using multivariate analysis of covariance adjusting for the total 24-h bile flow as the covariate. The multivariate analyses simultaneously considered: (a) hepatic concentration of the three lysosomal enzymes in one analysis; (b) the total 24-h output of the three lysosomal enzymes (after converting to log scale to stabilize variances in the two groups) in a second analysis; and (c) the hepatic concentration and 24-h total output (log scale) of iron in a third analysis. In addition, the 24-h outputs of the three lysosomal enzymes as a percentage of total liver content were each analyzed via a two-sample rank sum test (Wilcoxon test with continuity correction). Relationships between biliary outputs of iron and lysosomal enzymes were analyzed by regression analysis after log transformation of the data.
Results
Body weight, liver weight, bileflow, and serum levels of bilirubin and aspartate aminotransferase Inclusion of 2% carbonyl iron in the diet for 3 mo resulted in a significantly lower (P < 0.05) body weight (mean±SE) in ironloaded rats (n = 9, 383 g+18) compared with controls (n = 10, 429 g±2 1). There were no significant differences in liver weight between iron-loaded rats and control rats (11.5±0.6 vs. 10.8±0.5 g) or in bile flow (18.0±1.3 vs. 20.1±0.6 ml/24 h). When we compared total serum bilirubin and aspartate aminotransferase Fig. 1 A. Normal lysosome-like structures (arrows) are shown in the pericanalicular region. In contrast, an electron photomicrograph of the liver from an iron-loaded rat ( Fig. 1 B) shows electron dense granules within membrane-bound, pericanalicular organelles. These lysosomal-like structures, on higher magnification, contain hexagonal particles characteristic of ferritin (data not shown).
Quantitative morphometric analysis of the number of lysosomes in the pericanalicular area showed a progressive increase in the number of pericanalicular lysosomes as the duration of iron-loading was prolonged (Table II) . Indeed, a reasonable correlation (r = 0.65; P = 0.06) existed between the total hepatic iron content and the number of pericanalicular lysosomes.
X-ray microanalysis. The x-ray microanalysis energy emission spectra from an electron probe aimed at lysosomal or nonlysosomal areas in an iron-loaded rat is shown in Fig. 2 ; the peaks at 6.4 and 7.1 KeV are the characteristic emission spectra for iron. Note that large amounts of iron were detected in lysosomal areas compared with nonlysosomal areas. The relative concentration of iron in each probed area was determined by the area under the peaks at 6.4 and 7.1 KeV. Livers from rats that were serially iron-loaded from 1 to 27 wk were examined. We found a progressive rise in the relative amounts of iron in lysosomal areas with increasing duration of iron-loading (Table  II) . In contrast, relative amounts of iron in nonlysosomal areas remained unchanged with iron-loading (Table II) . In rats loaded for 3 mo, the ratio of iron in lysosomal areas compared with nonlysosomal areas was 19 to 1 (mean of eight probed areas from three rats). The high ratio of lysosomal to nonlysosomal iron concentration indicates that the excess iron is selectively compartmentalized to lysosomes.
Differential centrifugation. The subcellular distribution of iron was determined by differential centrifugation in a normal rat liver and livers from rats iron-overloaded for 1.5, 3, 5, and 61 wk (Fig. 3) by dietary carbonyl iron as described in Methods. In all animals studied, the majority of the iron was recovered in the S-fraction or cytosolic fraction. hepatic iron concentration and lysosomal latency was found (Fig. 4) .
Hepatic activity and biliary outputs oflysosomal enzymes
Activities in liver of the three lysosomal enzymes were significantly (P = 0.02) different in iron-loaded rats compared with controls (Table III) . Biliary outputs of all three lysosomal enzymes were significantly less in iron-loaded rats compared with controls (Table III) . Also, the activities of lysosomal enzymes excreted into bile in 24 h, expressed as a percentage of the total hepatic content of lysosomal enzymes, was significantly less in iron-loaded rats compared with controls (Table III Relationship between biliary iron output and release of lysosomal enzymes into bile
The relationship between the outputs into bile of iron and j3-galactosidase in control and iron-loaded rats is shown by regression analysis in Fig. 5 . In iron-loaded rats, there was a significant correlation between the two-hourly outputs of iron and (3-galactosidase (r = 0.88, P < 0.001). Similar significant correlations between two-hourly outputs ofiron and N-acetyl-f3-glucosaminidase (r = 0.85, P < 0.001) and 13-glucuronidase (r = 0.83, P < 0.001) were found. In contrast, in control rats, these relationships were poor and not significant: N-acetyl-fl-glucosaminidase (r =-0.417), fl-glucuronidase (r = -0.497), or j3-galactosidase (r =-0.432). In all rats studied, no significant relationships were found between the biliary excretion patterns of iron and alkaline phosphodiesterase I or total protein. A comparison of the 24-h excretory patterns for iron and a lysosomal enzyme in control and iron-loaded rats is shown in Fig. 6 . A similarity in excretory patterns for iron and N-acetyl-(-glucosaminidase is seen in the iron-loaded rats over 24 h.
Effect ofcolchicine on biliary excretion oflysosomal enzymes and iron
The outputs ofthe three lysosomal enzymes and iron were measured in bile after the injection of colchicine or normal saline in normal and iron-loaded rats (Fig. 7) . We had previously shown that colchicine, but not saline or lumicolchicine, markedly altered the release of lysosomal enzymes into bile. (6) The biliary output off(-galactosidase but not iron was altered in normal rats after the administration of colchicine (Fig. 7) ; these changes in Hours after injection Figure 7 . Biliary output of(3-galactosidase and iron in normal (n =I 1) or iron-loaded (n = 11) rats after the administration of saline or colchicine (50 ,mol/kg body wt biliary lysosomal enzyme output after colchicine were similar to those previously reported by us (6) . In contrast, I h after the administration ofcolchicine to iron-loaded rats, there was a parallel increase in the biliary outputs of both iron and gi-galactosidase compared with those given saline. There was a similar, parallel increase in the biliary outputs of iron and N-acetyl-fglucosaminidase (221% increase) and f3-glucuronidase (254% increase) after the administration of colchicine to iron-loaded rats (data not shown).
Discussion
The major findings of this study relate to subcellular aspects of biliary iron excretion. Our results show that, in the rat, experimental iron-overload causes a dramatic increase in hepatic iron content, a sequestration of excess iron in increased numbers of hepatocyte lysosomes, and an increase in biliary iron excretion that is closely coupled to the biliary outputs of three lysosomal enzymes under both basal and stimulated (i.e., colchicine treatment) conditions. We interpret these data to indicate that biliary iron excretion from hepatocyte lysosomes is a major excretory route for excess hepatic iron.
Effect ofiron-loading on hepatic and biliary iron. Iron-loading by oral carbonyl iron in the rat has advantages over other ironoverload models. We as well as Bacon et al. (16) have found this method to be efficient, since only 3 mo of oral iron-loading results in hepatic iron concentrations comparable to those found in genetic hemochromatosis. In addition, the cellular distribution of iron within the liver is predominantly in hepatocytes, a situation that is also similar to genetic hemochromatosis. In other experimental iron-overload models, the iron is distributed mostly within the nonparenchymal cells of the liver. Finally, as in early genetic hemochromatosis, iron deposition after iron-loading with carbonyl iron occurs predominately in periportal hepatocytes. Before this study, the subcelluar distribution of iron in the liver of this model had not been reported (see below). Inclusion of 2% carbonyl iron in the diet for 3 mo resulted in a 45-fold increase in hepatic iron compared with controls. This marked increase in hepatic iron concentration was associated with a twofold increase in biliary iron output. These observations have at least two implications: first, release of iron into bile may serve as an excretory pathway by which the liver can dispose of excess amounts of hepatic iron in conditions of hepatic iron-overload; and second, this excretory pathway for excess hepatic iron is limited, since a 45-fold increase in hepatic iron concentration was accompanied by only a twofold increase in biliary iron excretion. This latter situation contrasts with that seen in hepatic copper-overload in which there seems to be a greater ability of the liver to respond to states of excess hepatic copper by accelerating the rate of biliary copper excretion in proportion to the degree of hepatic copper-overload (29) .
Subcellular distribution ofhepatic iron. Several lines of evidence from this study using independent biochemical and morphologic techniques establish that the excess hepatic iron that accumulates after oral carbonyl iron is progressively sequestered in hepatocyte lysosomes. First, hepatocyte lysosomes in ironloaded rats were dramatically altered in their morphologic appearance; after 3 mo of iron-loading, pericanalicular lysosomes were enlarged and contained electron-dense, hexagonal material characteristic of ferritin. Second, using quantitative morphometric techniques, we observed a progressive increase in the number of pericanalicular lysosomes that paralleled the progressive increase in total hepatic iron. Third, x-ray microanalysis showed that these lysosome-like structures in the pericanalicular areas contained iron and that the ratio of lysosomal to nonlysosomal iron increased as the total hepatic iron content rose.
Hultcrantz et al. (28) have shown that the iron-containing organelles in iron overload liver are lysosomes using histochemical staining for acid phosphatase. Finally, there was a close, inverse correlation between the total hepatic iron content and the integrity of lysosomal membranes, as assessed biochemically by the latency of lysosomal N-acetyl-j3-glucosaminidase.
These morphologic and biochemical data indicate that the excess iron that accumulated in the hepatocytes after addition of 2% carbonyl iron to the diet of rats is largely if not entirely sequestered in hepatocyte lysosomes. In addition, the results show that the excess lysosomal iron markedly and progressively increases the fragility oflysosomes by an as yet unclear mechanism. Since lysosomal sequestration of excess hepatic iron and ironinduced, increased fragility of hepatocyte lysosomes are also hallmarks of genetic hemochromatosis (30) (2, (4) (5) (6) (7) suggest that there is bulk exocytic discharge of lysosomal contents into the biliary canaliculus. The demonstration of coupling between biliary iron excretion and release of lysosomal enzymes into bile in the iron-loaded rat suggests that the excess iron that accumulates in hepatocyte lysosomes after iron-loading is also released from lysosomes into bile by exocytosis. We have previously shown high concentrations of alkaline phosphodiesterase I in bile (2) and have proposed that this enzyme originates from the canalicular membrane. The coupling of biliary iron with lysosomal enzyme but not alkaline phosphodiesterase I suggests the biliary excretion of iron involves discharge of lysosomes into bile but not solubilization of canalicular membrane proteins.
The observation that iron-loading was associated with an increase in biliary iron excretion that occurred concomitantly with a decrease in biliary lysosomal enzyme release is difficult to interpret with confidence given our conclusion that biliary iron originates from hepatocyte lysosomes by bulk release. It certainly remains possible that we are underestimating the amount of lysosomal enzyme activity in the bile of iron-loaded rats, although this seems unlikely based on our in vitro mixing experiments. Reduced biliary output of lysosomal enzymes in iron-loaded rats could be due to a reduction in enzyme content per lysosome in conjugation with no alteration in the number of lysosomes releasing their contents into bile. We are not aware of a method to measure enzyme content per lysosome; therefore, this hypothesis cannot be readily tested. Another interpretation that we favor is that sequestration of excess iron in hepatocyte lysosomes somehow suppresses the fusion oflysosomes with the canalicular membrane. This interpretation would be compatible with the simultaneous increase in biliary excretion of iron seen in conjunction with the decrease in biliary excretion oflysosomal enzymes since fewer lysosomes containing larger amounts of iron would be available to fuse with the canalicular membrane to release their contents into bile. In addition, such an explanation would also conform to two other experimental results; first, that the number of lysosomes in the pericanalicular area increased after iron-loading, which suggests an accumulation of iron-loaded lysosomes around the canaliculus; and second, as discussed earlier, that the ability of the liver to accelerate its biliary excretion of excess iron sequestered in hepatocyte lysosomes is apparently limited. Whether such an apparent ironinduced suppression oflysosomal enzyme release into bile reflects iron-induced alterations in the lipid or protein composition of lysosomal membranes or damage to nonlysosomal cellular constituents involved in vesicle movement (e.g., microtubules) will need to be assessed in future studies.
We did not find a close relationship between biliary iron excretion and the release of lysosomal enzymes into bile in control rats under either basal or drug-stimulated conditions. These results suggest that in states of normal hepatic iron stores, biliary iron may be derived from a hepatocyte pool other than lysosomes. The source of biliary iron in control animals may be the cytosol since: (a) our tissue fractionation studies showed hepatic iron to be primarily localized to the cytosolic fraction in control rats whose lysosomal membranes were not fragile and in whom, therefore, such a localization is a valid description of the subcellular location of iron in vivo; and (b) our x-ray microanalysis studies did not demonstrate localization of iron in lysosomes in control rats.
Colchicine, a microtubule binding agent, has been shown in a variety ofcells to alter extracellular release ofexcretory products (32) (33) (34) by affecting the intracellular movement of vesicles. It seems likely that microtubules play a role in biliary iron excretion since we found that colchicine administration markedly altered biliary iron output in iron-loaded rats. Coichicine-enhanced release of iron into bile was associated with a concurrent augmentation in the excretion of lysosomal enzymes into bile, a finding that further supports our hypothesis that biliary iron is derived from hepatocyte lysosomes.
Higher biliary output of iron and of lysosomal enzymes in iron-loaded rats after the administration ofcolchicine may reflect an increased number of pericanalicular lysosomes in the condition of iron-overload associated with a colchicine-induced increased rate of fusion of hepatocyte lysosomes with biliary canaliculi. We have previously suggested the occurrence of such a "washout" effect based on our observations in normal rats of an increased release of lysosomal contents into bile, which was associated with a diminution in the number of pericanalicular lysosomes after the administration of colchicine (6) Pathophysiologic and therapeutic implications. Our data suggest that iron moves across the hepatocyte to the canaliculus by a vesicular transport process involving lysosomes. It has been proposed that the limited capacity of the cytocavitary network to excrete iron storage proteins is fundamental to the pathogenesis of cellular iron-overload (35) . Indeed, congenital or acquired iron-overloaded diseases of the liver might involve primary or secondary defects in lysosomal function. Supporting this concept is our observation of a significantly lower biliary lysosomal enzyme excretion in iron-loaded rats compared with controls, a finding which, as briefly discussed above, suggests excess iron may induce a defect in the lysosome-to-bile excretory pathway. Further experiments will be needed to define the role of altered vesicular transport in the pathogenesis of hepatic iron-overload.
Drugs that alter vesicular transport, such as colchicine, may have potential therapeutic benefit in patients with iron-overload diseases. The fate of biliary iron in the intestinal tract would determine the effectiveness of such a treatment. Biliary iron may have a similar fate to biliary copper, which is poorly absorbed by the intestine after biliary excretion (36) . We are currently investigating the fate ofbiliary iron in the intestine and the effect of long-term colchicine administration on hepatic iron concentrations and biliary iron excretion in iron-loaded rats.
